Gene Therapy Partially Restores Vision in Blind Patient in First Case of Its Kind
May 26, 2021: Gene Therapy Partially Restores Vision in Blind Patient in First Case of Its Kind
This author has not written his bio yet.
But we are proud to say that Bhushan Sreekrishnavilas contributed 237 entries already.
May 26, 2021: Gene Therapy Partially Restores Vision in Blind Patient in First Case of Its Kind
May 25, 2021: Design and Development of a Mobile-Based Self-Care Application for Patients with Type 2 Diabetes
May 22, 2021: Global Wolfram Syndrome Treatment Market Analysis 2021-2027 By Leading Companies: Harman Finochem, ROAQ CHEMICALS PVT. LTD., Eli Lilly and Company, Novo Nordisk, Astrazeneca, Glaxosmithkline Inc.
May 22, 2021: https://www.healthline.com/health/diabetes/diabetic-supplies
May 21, 2021: Apple releases new tools to meet the needs of folks with mobility, hearing and cognitive disabilities
May 20, 2021: Family Support for the Patient with Type 2 Diabetes Mellitus
May 20, 2021: https://medicalxpress.com/news/2021-03-fda-myrbetriq-children-neurogenic-detrusor.html
May 17, 2021: https://www.ideastream.org/news/blind-patients-hope-landmark-gene-editing-experiment-will-restore-their-vision
May 13, 2021: Effect of Ramadan Fasting on Body Mass Index of Type 2 Diabetes Mellitus Patients
May 11, 2021: Wolfram Syndrome and its Degenerative Factors and Treatments
The Snow Foundation is a collective voice for Wolfram syndrome patients, working towards a cure for Wolfram syndrome and developing novel therapies for diabetes, vision loss, hearing loss and neurodegeneration.
P.O. Box 50224 Clayton, MO 63105
(402) 694-1354
You must be logged in to post a comment.